首页> 外文期刊>Annals of the American Thoracic Society >Leptin and Adiponectin in Chronic Obstructive Pulmonary Disease Has the Fat Lady Sung?
【24h】

Leptin and Adiponectin in Chronic Obstructive Pulmonary Disease Has the Fat Lady Sung?

机译:慢性阻塞性肺疾病中的瘦素和脂联素是否有发胖的女士?

获取原文
获取原文并翻译 | 示例
           

摘要

Chronic obstructive pulmonary disease (COPD) is an inflammatory lung disease characterized by progressively worsening airflow limitation. The injury is initiated by an abnormal inflammatory reaction to environmental noxious stimuli that often continues even after removal of the offending agent. The mechanisms responsible for this self-perpetuating insult to the lung may be related to latent viral infection (1), impaired histone deacetylase activity (2), or oxidative stress (3) causing an amplified and continued inflammatory response. The reported range of lung function decline in COPD is highly variable. Several factors have been associated with more rapid lung function decline, such as chronic bronchitis, the presence of emphysema, current smoking, bronchodilator reversibility, and frequent exacerbations (4-6). To date, few interventions have been shown to decrease the progression of lung function decline other than smoking cessation (7).
机译:慢性阻塞性肺疾病(COPD)是一种炎症性肺疾病,其特征是气流限制逐渐恶化。伤害是由对环境有害刺激的异常发炎反应引起的,即使在除去有害物质后,这种反应仍会持续。导致这种自我永存的肺部损伤的机制可能与潜在的病毒感染(1),组蛋白脱乙酰基酶活性受损(2)或氧化应激(3)有关,从而引起放大的持续炎症反应。据报道,COPD的肺功能下降范围是高度可变的。肺功能快速下降与多种因素有关,例如慢性支气管炎,肺气肿,目前吸烟,支气管扩张剂可逆性和频繁发作(4-6)。迄今为止,除戒烟外,几乎没有干预措施能够减少肺功能下降的进展(7)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号